Also, since natalizumab is the highest risk PML-linked drug, when filtering the data we excluded instances for a given drug if natalizumab was also listed (i.e., oftentimes multiple drugs are listed for a given PML case). This evidence concerns the gene PML and progressive multifocal leukoencephalopathy.